Facet browsing currently unavailable
Page 4 of 2476 results
Sort by: relevance publication year
Antiviral resistance and direct-acting antiviral agents for HCV JOURNAL ARTICLE published 2012 in Antiviral Therapy |
Treatment of Acute HCV Infection in HIV-Positive Patients: Experience from a Multicentre European Cohort JOURNAL ARTICLE published February 2010 in Antiviral Therapy |
The science of direct-acting antiviral and host-targeted agent therapy JOURNAL ARTICLE published 2012 in Antiviral Therapy |
Effect of Abacavir on Acute Changes in Biomarkers Associated with Cardiovascular Dysfunction JOURNAL ARTICLE published May 2012 in Antiviral Therapy |
Evidence of a Significant Role for Fas-Mediated Apoptosis in HCV Clearance during Pegylated Interferon plus Ribavirin Combination Therapy JOURNAL ARTICLE published April 2011 in Antiviral Therapy |
Potential threat of drug-resistant and vaccine-escape HBV mutants to public health JOURNAL ARTICLE published 2010 in Antiviral Therapy |
Distinct Hepatitis C virus Kinetics in HIV-Infected Patients Treated with Ribavirin plus Either Pegylated Interferon α2a or α2b JOURNAL ARTICLE published May 2008 in Antiviral Therapy |
Providing access to high-quality, low-cost medicines across low and middle-income countries (LMICs), working with governments and generic manufacturers around the globe - A business case JOURNAL ARTICLE published April 2022 in Antiviral Therapy |
Very Late HCV Relapse following Triple Therapy for Hepatitis C JOURNAL ARTICLE published October 2014 in Antiviral Therapy |
First-line Highly Active Antiretroviral Regimens in 2001–2002 in the French Hospital Database on HIV: Combination Prescribed and Biological Outcomes JOURNAL ARTICLE published April 2007 in Antiviral Therapy |
Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy JOURNAL ARTICLE published February 2003 in Antiviral Therapy |
Long-Term Foscarnet Therapy Remodels Thymidine Analogue Mutations and Alters Resistance to Zidovudine and Lamivudine in HIV-1 JOURNAL ARTICLE published April 2007 in Antiviral Therapy |
Real-life findings on the impact of the COVID-19 pandemic on HIV care JOURNAL ARTICLE published May 2021 in Antiviral Therapy |
A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-Nucleoside Polymerase Inhibitor JOURNAL ARTICLE published May 2018 in Antiviral Therapy |
Antiviral Therapy of Haemorrhagic Fevers and Arbovirus Infections JOURNAL ARTICLE published February 1998 in Antiviral Therapy |
Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects with Renal Function Impairment JOURNAL ARTICLE published July 2015 in Antiviral Therapy |
The Host–pathogen Interaction during HBV Infection: Immunological Controversies JOURNAL ARTICLE published April 2010 in Antiviral Therapy |
NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected with HCV Genotypes 1–5 JOURNAL ARTICLE published October 2011 in Antiviral Therapy |
Changing strategies for hepatitis C testing JOURNAL ARTICLE published 2012 in Antiviral Therapy |
Resistance data in the ARTEN trial JOURNAL ARTICLE published 2011 in Antiviral Therapy |